Summary
How ALO maps according to Revere
| Sector Level | Count |
|---|---|
Industries
|
1 |
Sectors
|
2 |
Subsectors
|
4 |
Product/Service Groups
|
8 |
Specific product example for ALO
| Product Hierarchy |
|---|
Healthcare
|
Biopharmaceuticals
|
Endocrinology/Metabolism
|
Pituitary Gland Disorders
|
Pituitary Hyperthyroidism (TSH-Induced)
|
Thyroid Hormones
|
Company Highlights:
Market Cap.
|
1,988.415 |
Current Shares Outstnd.
|
53.8 |
| Contact Name | Thomas J. Spellman III |
| Contact Phone | (866)3222525 |
| City, State | Bridgewater, NJ |
| Dividends Per Common Share | 0.00 |
| Dividend Yield | 0.00 |
SI %SHOUT
|
6.24 |
IH % Shares Outst.
|
n/a |
| Number of Employees | 2,000 |
| Revenue Per Employee | 352,361.4 |
| Book Value Per Share | 14.61 |
| 5 Year CAGR in Revenues % | -15.35 |
| 5 Year CAGR in Earnings % | -4.60 |
Asset Turnover
|
0.13 |
| Fiscal Year End | 12/31/2008 |
| Next Reporting Period | Dec, 2008 |
Business Description:
Chart:
| Last Price | 36.99 |
| Price Chg. | 0.00 |
| Price Chg. % | 0.00% |
| Open Price | 36.93 |
| High Price | 36.99 |
| Low Price | 36.88 |
| 52w High Price | 38.14 |
| 52w Low Price | 17.55 |
| Volume | 1,199,955 |
| 30d Avg. Volume | 774,771 |
Competitors by Products
| Products Manufactured/Services Performed/Product Name(s) - Competitors (Tickers)/Product Name(s): |
|---|
Healthcare
|
Biopharmaceuticals
|
Endocrinology/Metabolism
|
Pituitary Gland Disorders
|
Pituitary Hyperthyroidism (TSH-Induced)
|
Thyroid Hormones
Products:
Abbott Laboratories (ABT) Products:
GeoPharma, Inc. (GORX) Products:
K-V Pharmaceutical Company (KV/A) Products:
King Pharmaceuticals, Inc. (KG) Products:
Lannett Company, Inc. (LCI) Products:
Mylan Inc. (MYL) Products:
Novartis AG (ADR) (NVS) Products:
|
Thyroid Gland Disorders
|
Hypothyroidism
|
Thyroid Hormones
Products:
Abbott Laboratories (ABT) Products:
Forest Laboratories, Inc. (FRX) Products:
GeoPharma, Inc. (GORX) Products:
K-V Pharmaceutical Company (KV/A) Products:
King Pharmaceuticals, Inc. (KG) Products:
Lannett Company, Inc. (LCI) Products:
Mylan Inc. (MYL) Products:
Novartis AG (ADR) (NVS) Products:
|
Musculoskeletal System
|
Skeletal Disorders
|
Joint Disorders
|
Osteoarthritis (OA)
|
Non-Steroidal Anti-Inflammatory Drugs (NSAID)
|
Non-Specific Cyclooxygenase Inhibitors (COX Inhibitors)
Products:
Baxter International Inc. (BAX) Products:
Biovail Corporation (USA) (BVF) Products:
Caraco Pharmaceutical Laboratories Ltd. (CPD) Products:
Dr. Reddy's Laboratories Limited (ADR) (RDY) Products:
Endo Pharmaceuticals (ENDP) Products:
GlaxoSmithKline plc (ADR) (GSK) Products:
Johnson & Johnson (JNJ) Products:
K-V Pharmaceutical Company (KV/A) Products:
Merck & Co., Inc. (MRK) Products:
Mylan Inc. (MYL) Products:
Novartis AG (ADR) (NVS) Products:
Nuvo Research Inc. (NRI:CA) Products:
Par Pharmaceutical Companies, Inc. (PRX) Products:
Perrigo Company (PRGO) Products:
Pfizer Inc. (PFE) Products:
Roche Holding Ltd. (ADR) (RHHBY) Products:
Santarus, Inc. (SNTS) Products:
Taro Pharmaceutical Industries Ltd. (TAROF) Products:
Teva Pharmaceutical Industries Ltd (ADR) (TEVA) Products:
Watson Pharmaceuticals, Inc. (WPI) Products:
Wyeth (WYE) Products:
|
Pain Management
|
Anesthesia
|
General (Systemic)
|
Adjunctive
|
Opioids
Products:
Akorn, Inc. (AKRX) Products:
Baxter International Inc. (BAX) Products:
Hospira, Inc. (HSP) Products:
Johnson & Johnson (JNJ) Products:
Lannett Company, Inc. (LCI) Products:
Novartis AG (ADR) (NVS) Products:
Valeant Pharmaceuticals International (VRX) Products:
|
Narcotics
|
Opioids
Products:
Abbott Laboratories (ABT) Products:
Acura Pharmaceuticals, Inc. (ACUR) Products:
Akorn, Inc. (AKRX) Products:
Baxter International Inc. (BAX) Products:
BioDelivery Sciences International, Inc. (BDSI) Products:
Biovail Corporation (USA) (BVF) Products:
Caraco Pharmaceutical Laboratories Ltd. (CPD) Products:
Cephalon, Inc. (CEPH) Products:
Cipher Pharmaceuticals Inc (DND:CA) Products:
Covidien Ltd. (COV) Products:
DURECT Corporation (DRRX) Products:
Endo Pharmaceuticals (ENDP) Products:
Hospira, Inc. (HSP) Products:
Javelin Pharmaceuticals Inc. (JAV) Products:
Johnson & Johnson (JNJ) Products:
K-V Pharmaceutical Company (KV/A) Products:
King Pharmaceuticals, Inc. (KG) Products:
Labopharm Inc. (DDSS) Products:
Lannett Company, Inc. (LCI) Products:
Ligand Pharmaceuticals Inc. (LGND) Products:
Mylan Inc. (MYL) Products:
Novartis AG (ADR) (NVS) Products:
Pain Therapeutics, Inc. (PTIE) Products:
Penwest Pharmaceuticals (PPCO) Products:
SkyePharma PLC (ADR) (SKYPY) Products:
Teva Pharmaceutical Industries Ltd (ADR) (TEVA) Products:
Valeant Pharmaceuticals International (VRX) Products:
Watson Pharmaceuticals, Inc. (WPI) Products:
|
Non-Narcotics
|
Non-Steroidal Anti-Inflammatory Drugs (NSAID)
|
Non-Specific Cyclooxygenase Inhibitors (COX Inhibitors)
Products:
Abraxis Bioscience, Inc. (ABII) Products:
Akorn, Inc. (AKRX) Products:
Baxter International Inc. (BAX) Products:
Bayer AG (ADR) (BAYRY) Products:
Caraco Pharmaceutical Laboratories Ltd. (CPD) Products:
Chattem Inc. (CHTT) Products:
Dr. Reddy's Laboratories Limited (ADR) (RDY) Products:
Endo Pharmaceuticals (ENDP) Products:
GlaxoSmithKline plc (ADR) (GSK) Products:
Javelin Pharmaceuticals Inc. (JAV) Products:
Johnson & Johnson (JNJ) Products:
K-V Pharmaceutical Company (KV/A) Products:
Merck & Co., Inc. (MRK) Products:
Mylan Inc. (MYL) Products:
Novartis AG (ADR) (NVS) Products:
Par Pharmaceutical Companies, Inc. (PRX) Products:
Perrigo Company (PRGO) Products:
Prestige Brands Holdings, Inc. (PBH) Products:
Roche Holding Ltd. (ADR) (RHHBY) Products:
Taro Pharmaceutical Industries Ltd. (TAROF) Products:
Teva Pharmaceutical Industries Ltd (ADR) (TEVA) Products:
Watson Pharmaceuticals, Inc. (WPI) Products:
Wyeth (WYE) Products:
|
Phase I/Phase II Clinical Stage Products
Products:
ACADIA Pharmaceuticals Inc. (ACAD) Products:
Adolor Corporation (ADLR) Products:
Akela Pharma Inc. (AKL:CA) Products:
Alexza Pharmaceuticals, Inc. (ALXA) Products:
Allergan, Inc. (AGN) Products:
Amgen, Inc. (AMGN) Products:
Anesiva, Inc. (ANSV) Products:
Aradigm Corporation (ARDM) Products:
Array BioPharma Inc. (ARRY) Products:
AstraZeneca plc (ADR) (AZN) Products:
Avigen, Inc. (AVGN) Products:
BioDelivery Sciences International, Inc. (BDSI) Products:
Cephalon, Inc. (CEPH) Products:
DARA BioSciences, Inc. (DARA) Products:
DepoMed, Inc. (DEPO) Products:
DURECT Corporation (DRRX) Products:
Eisai Co., Ltd (ADR) (ESALY) Products:
Eli Lilly & Co. (LLY) Products:
Elite Pharmaceuticals, Inc. (ELI) Products:
Endo Pharmaceuticals (ENDP) Products:
EpiCept Corporation (EPCT) Products:
Evotec AG (ADR) (EVTC) Products:
Forest Laboratories, Inc. (FRX) Products:
Generex Biotechnology Corporation (GNBT) Products:
GlaxoSmithKline plc (ADR) (GSK) Products:
Indevus Pharmaceuticals (IDEV) Products:
Javelin Pharmaceuticals Inc. (JAV) Products:
Johnson & Johnson (JNJ) Products:
King Pharmaceuticals, Inc. (KG) Products:
Labopharm Inc. (DDSS) Products:
Merck & Co., Inc. (MRK) Products:
Neurobiological Technologies, Inc. (NTII) Products:
Neurocrine Biosciences, Inc. (NBIX) Products:
Neurogen Corporation (NRGN) Products:
NeurogesX, Inc (NGSX) Products:
Novadel Pharma Inc (NVD) Products:
Novartis AG (ADR) (NVS) Products:
Pain Therapeutics, Inc. (PTIE) Products:
Penwest Pharmaceuticals (PPCO) Products:
Pfizer Inc. (PFE) Products:
Pharmos Corporation (PARS) Products:
POZEN Inc. (POZN) Products:
Questcor Pharmaceuticals, Inc. (QCOR) Products:
Roche Holding Ltd. (ADR) (RHHBY) Products:
Sanofi-Aventis SA (ADR) (SNY) Products:
SkyePharma PLC (ADR) (SKYPY) Products:
Solvay S.A. (ADR) (SVYSY) Products:
Targacept , Inc. (TRGT) Products:
TorreyPines Therapeutics Inc. (TPTX) Products:
Valeant Pharmaceuticals International (VRX) Products:
Vernalis plc (ADR) (VNLSY) Products:
XenoPort, Inc. (XNPT) Products:
YM BioSciences Inc. (USA) (YMI) Products:
|
Veterinary Products and Services
|
Veterinary Pharmaceuticals
Products:
Akzo Nobel N.V. (ADR) (AKZOY) Products:
Anika Therapeutics, Inc. (ANIK) Products:
AspenBio Pharma, Inc. (APPY) Products:
Bayer AG (ADR) (BAYRY) Products:
Bioniche Life Sciences (BNC:CA) Products:
Biopure Corporation (BPUR) Products:
Celldex Therapeutics, Inc. (CLDX) Products:
Eli Lilly & Co. (LLY) Products:
GeoPharma, Inc. (GORX) Products:
Heska Corporation (HSKA) Products:
IDEXX Laboratories, Inc. (IDXX) Products:
ImmuCell Corporation (ICCC) Products:
Jazz Pharmaceuticals, Inc. (JAZZ) Products:
Lipid Sciences, Inc. (LIPD) Products:
Merck & Co., Inc. (MRK) Products:
Minrad International, Inc. (BUF) Products:
Neogen Corporation (NEOG) Products:
Oculus Innovative Sciences, Inc. (OCLS) Products:
Pfizer Inc. (PFE) Products:
Polydex Pharmaceuticals Limited (USA) (POLXF) Products:
Sanofi-Aventis SA (ADR) (SNY) Products:
Schering-Plough Corporation (SGP) Products:
SemBiosys Genetics Inc. (SBS:CA) Products:
Teva Pharmaceutical Industries Ltd (ADR) (TEVA) Products:
The Quigley Corporation (QGLY) Products:
Vical Incorporated (VICL) Products:
Wyeth (WYE) Products:
|
Key Financials
| Period Length/End |
3 months ending 09/30/2008 |
3 months ending 06/30/2008 |
3 months ending 09/30/2007 |
12 months ending 12/31/2007 |
12 months ending 12/31/2006 |
12 months ending 12/31/2005 |
| Total Revenue | 175.7 | 166.9 | 133.2 | 534.8 | 653.8 | 553.6 |
Gross Margin %
|
64.08 | 64.66 | 61.33 | 61.8 | 58.4 | 60.74 |
Operating Income
|
9.7 | -5.2 | 12.5 | -32.2 | 76.2 | 86.8 |
Operating Margin %
|
5.55 | -3.12 | 9.39 | -6.02 | 11.65 | 15.68 |
| Tax Rate % | 63.57 | 64.57 | 66.43 | -92.41 | 35.15 | -42.03 |
| Income After Taxes | 4.1 | -0.9 | 5.3 | -43.1 | 60.0 | 62.2 |
| Net Income Margin % | 2.34 | -0.51 | 3.96 | -8.06 | 9.18 | 11.23 |
F.D. EPS - Incl. Xord. Items
|
0.10 | -0.17 | 0.34 | -0.32 | 1.52 | 2.52 |
| Book Value Per Share | 14.61 | 14.81 | 14.01 | 13.13 | 13.17 | 16.98 |
Ratios
P/R Ratio (TTM)
|
3.06 |
P/E Ratio (TTM)
|
17.42 |
| Price To Free Cash Flow (TTM) | -21.37 |
| Price To Book Value | 3.23 |
| Net Assets to Market Cap. % | 51.25% |
| Beta | 0.49 |
Days to Sell Inventory
|
176.38 |
Current Ratio
|
4.49 |
Quick Ratio
|
3.65 |
| Interest Coverage | n/a |
| Debt to Market Cap. % | 15.09% |
| Return on Equity % | -11.9 |
| Return on Assets % | -6.9 |
| Return on Invested Capital % | -9.16 |
Business/Geographical Segments
Business Segments
| External Revenue | Total Revenue | Operating Income/Loss | Operating Margin (%) | ||||
|---|---|---|---|---|---|---|---|
| Branded Pharmaceuticals | 82.1 | 46.7% | 82.1 | 46.7% | 9.1 | 35.4% | 11.10% |
| Animal Health Division | 93.6 | 53.3% | 93.6 | 53.3% | 16.6 | 64.6% | 17.73% |
| Segment Total | 175.7 | 100.0% | 175.7 | 100.0% | 25.7 | 100.0% | 14.63% |
| Eliminations | -16.0 | ||||||
| Consolidated Total | 175.7 | 175.7 | 9.7 | 5.55% | |||